Safety Evaluation of Parastar® Plus in Dogs and Assessment of Transferable Residue of Fipronil and Cyphenothrin from Dogs to Humans by Katharine M. Case et al.
September 2016 | Volume 3 | Article 891
Original research
published: 30 September 2016
doi: 10.3389/fvets.2016.00089
Frontiers in Veterinary Science | www.frontiersin.org
Edited by: 
Nora Mestorino, 




Ankara University, Turkey  
Philippe Jacques Berny, 
VetAgro Sup, France
*Correspondence:
Ramesh C. Gupta  
rgupta@murraystate.edu
Specialty section: 
This article was submitted 
to Veterinary Pharmacology 
and Toxicology, 
a section of the journal 





Case KM, Vega NM, Gupta RC, 
Lasher MA and Canerdy TD (2016) 
Safety Evaluation of Parastar® Plus in 
Dogs and Assessment of 
Transferable Residue of Fipronil and 
Cyphenothrin from Dogs to Humans. 
Front. Vet. Sci. 3:89. 
doi: 10.3389/fvets.2016.00089
safety evaluation of Parastar® 
Plus in Dogs and assessment of 
Transferable residue of Fipronil and 
cyphenothrin from Dogs to humans
Katharine M. Case1,2, Natalia M. Vega1,2, Ramesh C. Gupta1*, Michelle A. Lasher1 and 
Terry D. Canerdy2
1 Toxicology Department, Breathitt Veterinary Center, Murray State University, Hopkinsville, KY, USA, 2 Murray State University, 
Murray, KY, USA
Dogs are easily infested with fleas, ticks, and other ectoparasites serving as vectors for 
transmitting bacterial, viral, and parasitic diseases. Therefore, the use of ectoparasiticides is 
inevitable and important. The present investigation was undertaken with two specific objec-
tives: one, to evaluate the safety of fipronil and cyphenothrin in dogs after topical application 
of Parastar® Plus, and two, to determine the transferable residue of these insecticides from 
dogs to humans. Six healthy, adult dogs (medium length hair, weighing between 20.5 and 
27.3 kg) received topical application of Parastar® Plus (2.68 mL; fipronil, 9.8%, and cyphe-
nothrin, 5.2%) on the back between the shoulder blades. At predetermined intervals, dogs 
were given a full physical exam, and residues of fipronil and cyphenothrin were determined 
in dog blood and cotton glove extracts using GC/MS. Fipronil and cyphenothrin peaks 
eluted at 7.453 and 9.913  min, correspondingly, and the compounds were confirmed 
based on characteristic ions. At no time was fipronil or cyphenothrin residue detected in 
blood samples. In glove extracts, residues of fipronil and cyphenothrin were maximally 
present at 24-h posttreatment (43.84 ± 5.69 and 59.26 ± 8.97 ppm, respectively). By 48 h, 
the residue levels sharply declined (16.89 ± 2.82 and 17.98 ± 2.07 ppm, respectively). The 
insecticides’ residues were detected in insignificant amounts after 1 week (5.69 ± 2.16 
and 10.00 ± 1.51 ppm, respectively), and only in trace amounts after 2 weeks. At no time 
did any dog show side effects, except itching at the site of Parastar® Plus application. The 
findings suggest that Parastar® Plus was safe for dogs, and transferable residues of fipronil 
and cyphenothrin were minimal, posing very little or no health concern to pet owners or 
veterinary personnel. Of course, veterinary personnel, who handle many dogs daily, may 
require proper protection to avoid cumulative exposure.
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inTrODUcTiOn
Currently, there are approximately 80 million dogs residing alongside humans in North America. 
Dogs serve as hosts for several ectoparasites, such as fleas, ticks, lice, and mites. These ectoparasites are 
capable of spreading many diseases that are significant for both animal and human health. Zoonotic 
diseases spread by ectoparasites include Lyme disease, plague, ehrlichiosis, Rocky Mountain spot-
ted fever, scabies, and several others. Internal parasites can also be transmitted, such as the flea 
FigUre 1 | The chemical structures of (a) fipronil and (B) 
cyphenothrin.
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tapeworm (Dipylidium caninum) that frequently infects children 
(1). Currently, in more than fifteen countries, microcephaly in 
thousands of babies born to mothers exposed to Zika virus spread 
by mosquitoes is the most serious human health concern. Because 
of the close contact between dogs and humans, and the variety 
of disease vectors for which dogs serve as the host, treatment of 
ectoparasites is important and inevitable.
Parastar® Plus for Dogs (subsequently referred to as Parastar® 
Plus) is a monthly topical ectoparasiticide developed by Novartis 
Animal Health. It kills fleas, several species of ticks, and it con-
trols chewing lice and sarcoptic mange mites (2). The product 
contains two active ingredients: (1) fipronil: (±)-5-amino-1-
[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)
sulfinyl]-1H-pyrazole-3-carbonitrile, 9.8% and (2) cyphenothrin: 
[cyano-(3-phenoxyphenyl) methyl] 2,2-dimethyl-3-(2-methyl-
prop-1-enyl)cyclopropane-1-carboxylate, 5.2%. The chemical 
structures of fipronil and cyphenothrin are shown in Figure 1.
According to the manufacturer, Parastar® Plus begins work-
ing within 5 min of application and maintains effectiveness for 
30 days (3). It kills fleas (Ctenocephalides spp.), four species of 
ticks (Dermacentor variabilis, Ixodes spp., Amblyomma america-
num, and Rhipicephalus sanguineus), mites (Sarcoptes scabiei var. 
canis), and lice (order Mallophaga), many of which are vectors for 
zoonotic diseases of humans.
Fipronil is a phenylpyrazole insecticide that was first devel-
oped as an agricultural pesticide in 1987. Due to its lipophilic 
nature, fipronil is absorbed by the sebaceous glands of the skin, 
leading its distribution throughout the skin and hair follicles 
(4, 5), thereby providing ectoparasiticide effect for a month.
Pyrethroids are semisynthetic derivatives of naturally occur-
ring pyrethrins extracted from flowers of the chrysanthemum 
plant (Chrysanthemum cinerariaefolium). Pyrethroids are of two 
types (type I and type II). Type II pyrethroids are distinguished 
from type I by having an α-cyano group at the molecule’s alcohol 
moiety that increases its insecticidal activity. Cyphenothrin 
is a type II pyrethroid that was first registered at the US 
Environmental Protection Agency (EPA) in 1991. Like fipronil, 
cyphenothrin also exhibits lipophilic tendencies that allow it to 
be distributed among fatty tissue (6) and in oily sebaceous gland 
secretions.
Safety evaluation of Parastar® Plus (active ingredients, fipronil, 
and cyphenothrin) in dogs and transferable residues of these 
insecticides from dogs to humans have not yet been reported. 
The current investigation was therefore undertaken to evaluate 
the safety of Parastar® Plus in dogs. Further, since the risk of 
continuous exposure due to repeated application of Parastar® 
Plus for children and pet owners exists, the present investigation 




Six, privately owned adult dogs (various breeds, with medium 
length hair coats) weighing between 20.5 and 27.3 kg (45–60 lbs) 
served as the participants in this investigation, representing both 
the control (pretreatment) and the experimental (treatment) 
groups. Each of the dog’s owners signed a consent form detailing 
the experimental protocol and any risks involved with ectopara-
siticide use. Two weeks prior to the beginning of the study, the 
dogs were taken off any current ectoparasiticides, as well as 
heartworm prevention. Blood and glove samples were collected 
on day 0 and were tested for residues of fipronil, cyphenothrin, 
and any other chemicals. All of the dogs were negative for chemi-
cal residues.
chemicals
Parastar® Plus was purchased from 1 to 800 PetMeds® (Novartis 
Animal Health US, Inc., Greensboro, NC, USA). A single applica-
tion of the product contained 2.68 mL (fipronil 9.8%; cypheno-
thrin 5.2%) for dogs weighing 45–88 lbs (20.5–40 kg). Analytical 
grade standards of fipronil and cyphenothrin were purchased 
from Chem Service, Inc. (West Chester, PA, USA).
Biohazards
Murray State University’s policy and procedures were followed in 
this investigation for the disposal of dog blood and gloves.
experimental Design
The experimental design of this investigation was based upon 
previous studies conducted at Murray State University and else-
where (4, 7–10). In this study, each dog served as its own control. 
The study protocol was approved by Murray State University’s 
Institutional Animal Care and Use Committee (IACUC). The 
IACUC committee approved the use of six dogs based on power 
analysis.
Parastar® Plus application
Parastar® Plus was topically applied in the amount of 2.68  mL 
directly to the skin between the shoulder blades, according to the 
manufacturer’s instructions (2).
Physical examination
At predetermined intervals, dogs were given a physical examina-
tion for the measurement of body weight, heart rate, respiration 
rate, and body temperature. The dogs were examined for any 
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change in their behavior and the skin was examined for signs of 
irritation (such as erythema) at the site of Parastar® Plus applica-
tion. Owners were questioned about their dog’s behavior and 
whether they observed the dogs itching at the application site.
sample collection
Sampling included blood and topical glove collection. Whole 
blood (3.5–5.0 mL) was collected from the jugular vein in EDTA 
tubes on day 0 and at 24, 48, and 72 h, and 1-week post-application 
of Parastar® Plus. Blood samples were stored in the refrigerator 
until analysis within 72 h. Topical samples were collected using 
the wipe sampling technique during which the investigator wore 
a 100% cotton glove on one hand and pet the dog along its sides 
and back continuously for 5 min, avoiding the application site. 
Topical samples were collected on day 0, at 24, 48, and 72 h, and at 
1, 2, 3, and 4 weeks post-application of Parastar® Plus. The gloves 
were then placed into individual (473 mL) glass jars and stored at 
room temperature until analysis within 72 h.
sample extraction
Blood samples were transferred from EDTA tubes to individual 
(500 mL) separatory funnels and weighed. Twenty-five milliliter 
of methylene chloride: petroleum ether (1:1) was added, and 
the funnels were gently shaken three times and allowed to vent 
between shakes. The samples sat for 30 min, and then a disposable 
pipette was used to draw off the solvent and pass it through a 
sodium sulfate-filled filter into a 50 mL beaker. The solvent was 
swirled and passed through the filters. A syringe and needle were 
used to aspirate the remaining 2–3 mL and pass it through a Sep-
Pak® cartridge (Waters Corp., Milford, MA, USA) into a clean 
tube. After it evaporated to dryness, it was reconstituted in an 
appropriate volume of methylene chloride: petroleum ether for 
fipronil and cyphenothrin residue analysis by GC/MS.
Gloves were removed from the glass jars, weighed, and then 
placed into individual 250 mL beakers. Hundred milliliter meth-
ylene chloride: petroleum ether (1:1) was added, and the gloves 
swirled and fully submerged in the solvent, after which they were 
allowed to sit for 30 min. The solvent was then poured through 
a sodium sulfate-filled filter into a new 100 mL beaker. During 
evaporation, the remaining 2–3 mL of solvent were aspirated with 
a needle and syringe and passed through a Sep-Pak® cartridge 
into a clean tube. After it evaporated to dryness, it was reconsti-
tuted in an appropriate volume of methylene chloride: petroleum 
ether for fipronil and cyphenothrin residue analysis by GC/MS.
gc/Ms analysis
The active ingredients of Parastar® Plus (fipronil and cypheno-
thrin) were confirmed and quantified using an agilent gas chro-
matograph (GC model 7890A)/mass spectrometer (MS model 
5975C) coupled with a computer, and their concentrations were 
expressed in terms of microgram per gram (parts per million). 
One microliter of the reconstituted extract was injected into the 
GC. The capillary column used was Ultra II cross-linked with 5% 
phenyl methyl siloxane coating and was of the following dimen-
sions (25  m ×  0.52 μm), which was directly connected to the 
Mass Selective Detector via an interface and heated transfer line. 
The carrier gas was ultrapure (99.9999%) helium at a flow rate of 
2.3 mL/min, and the injector temperature was 200°C. The injector 
was operated in the splitless mode. A temperature program for the 
GC-oven was used starting at a temperature of 100°C, and then 
increased to a final temperature of 300°C in 20°C/min increments. 
The final temperature was maintained for 5 min. The transfer line 
temperature was 280°C, and the source temperature was 230°C. 
The instrument was operated in electron ionization mode, and 
the ion energy was 70  eV. The total duration of each injection 
run was 16 min, with a solvent delay of 7 min. Peaks of fipronil 
and cyphenothrin eluted at 7.453 and 9.913  min, respectively. 
Sensitivity of the GC/MS for these compounds was in the range 
of nanogram, and the limit of detection was in the low microgram 
per gram (parts per million) range. Total ion chromatograms and 
mass spectra with characteristic ions for fipronil (77.1, 179, 213, 
255, 367, 417, and 436) and cyphenothrin (81.1, 123.1, 152.1, 
167.1, 181.1, 208.1, and 375.2) are presented in Figures 2 and 3, 
respectively. The identification and confirmation of each insec-
ticide was based on characteristic ion-based spectrum. Percent 
recovery for fipronil and cyphenothrin was greater than 95%.
resUlTs
adverse reactions
At no time during this investigation were adverse reactions to 
Parastar® Plus observed in any of the dogs. Some participants 
experienced itching following application, as observed by 
the owners. It cannot be stated definitively that application 
of Parastar® Plus caused the clinical signs observed, as patient 
histories before the study were not entirely known. It was pos-
sible that one participant displayed scratching behavior due to an 
ongoing flea infestation. Flea dirt was observed in this dog’s hair 
coat throughout the study.
Fipronil and cyphenothrin concentrations 
in Blood and glove samples
The skin and hair coat residue levels of Parastar® Plus’s active 
ingredients, fipronil (9.8%) and cyphenothrin (5.2%), were 
expected to reach maximum concentrations at 24-h post-
application. In blood, due to slow dermal absorption (11), the 
maximum concentrations of fipronil and cyphenothrin were 
expected at 24- to 48-h post-application. Because Parastar® Plus 
is designed to provide protection for 30 days, insecticide residues 
on hair coat were expected to be detectable for up to 4  weeks 
post-application. Residue persistence on hair coat corresponded 
with these expectations.
At no time throughout the study duration were fipronil and 
cyphenothrin detected in blood samples. Data of fipronil and 
cyphenothrin concentrations in glove extracts are presented in 
Figures 4 and 5, respectively. Fipronil showed the highest con-
centration levels in gloves at 24-h post-application with a range 
of 22.23–59.66 ppm (43.83 ± 5.69 ppm). At the same time point, 
cyphenothrin concentration was in the range of 26.24–90.40 ppm 
(59.26 ± 8.97 ppm). At 48-h post-application, residues for both 
fipronil and cyphenothrin exhibited a steep decline (16.89 ± 2.82 
and 17.98 ± 2.07 ppm, respectively) from the 24-h values. At 72 h, 
the value for fipronil was 8.31 ± 1.69 ppm, and for cyphenothrin 
it was 16.60 ± 3.19 ppm.
FigUre 2 | Total ion chromatogram (upper panel) and ion spectrum (lower panel) of fipronil.
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One week after Parastar® Plus application, the value of fipronil 
was 5.69 ± 2.16 ppm, and of cyphenothrin was 10.00 ± 1.51 ppm. 
With a decreasing trend at 4  weeks post-application, the value 
for fipronil was 1.09  ±  0.13  ppm, and for cyphenothrin was 
0.43 ± 0.28 ppm.
DiscUssiOn
The present investigation was undertaken with two specific objec-
tives: (1) to evaluate the safety of Parastar® Plus in dogs; and (2) to 
measure the transferable residue of the active ingredients (fipronil 
and cyphenothrin) of Parastar® Plus from dog coats to humans. 
Determining the level of transferable residues of insecticides can 
aid in assessing the level of exposure and risks to pet owners, 
veterinary professionals, dog trainers, police, and military K9 
units from dogs topically treated with Parastar® Plus.
The results of this study suggest a high level of safety in the use 
of Parastar® Plus for routine ectoparasite control in dogs, if the 
manufacturer’s instructions are followed. At no time during this 
investigation, were adverse reactions to Parastar® Plus observed 
in any of the dogs. Also, at no time were residues of fipronil and 
cyphenothrin detected in the dogs’ blood. This indicates that the 
dermal absorption of fipronil and cyphenothrin is minimal or 
insignificant, and systemic exposure to these insecticides for dogs 
is extremely limited. Further, no risk of exposure to insecticides 
via contact with blood exists for veterinary personnel. Residues of 
FigUre 3 | Total ion chromatogram (upper panel) and ion spectrum (lower panel) of cyphenothrin.
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fipronil and cyphenothrin on the dogs’ hair coats were found to be 
maximal at 24 h (43.83 ± 5.69 and 59.26 ± 8.97 ppm, respectively) 
post-Parastar® Plus application. The manufacturer advises that pet 
owners limit contact with their dogs during the first 24 h to allow 
the product to fully dry at the site of application. If this instruction 
is heeded, the risk of accidental exposure to Parastar® Plus through 
coat residues is greatly diminished. Of course, local irritation and 
local reactions could still be observed but have been investigated 
in this study. This aspect of investigation will be pursued in future 
studies. Insecticide residues drastically reduced by 48 h from 24 h 
(fipronil, 61.5% and cyphenothrin, 69.7%). If this 24-h time frame 
is observed by pet owners, accidental, oral, or dermal exposure to 
the product would be unlikely, even in children or pet cats.
In the setting of a veterinary clinic, a number of factors can 
influence the level of insecticide transfer from dogs to veterinary 
personnel, such as the type of patients seen, the volume of the 
practice, the number of exposure events occurring per day, and 
whether members of the staff are observing safety measures like 
wearing gloves while contacting patients.
In 2009 and 2010, the EPA investigated an increase observed 
in reports of adverse reactions to spot-on ectoparasiticides from 
2007 to 2008. Cyphenothrin, in addition to other pyrethrins/
pyrethroids, was among one of the active ingredients highly 
represented across reports. Small breed dogs and cats were more 
commonly reported to experience adverse effects to spot-on 
products (12). The EPA suggested three explanations for why 
FigUre 5 | concentrations of cyphenothrin in gloves (mean ± seM).
FigUre 4 | concentrations of fipronil in gloves (mean ± seM).
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small animals were more susceptible than large animals to the 
use of these products. One, the weight range for spot-on treat-
ments might vary too greatly. For example, the dose (2.68 mL) of 
Parastar® Plus used in the current study was for the weight range 
of 20.5–40 kg. Dogs on the lower end of the range might be receiv-
ing twice the dose compared to those at the higher end. Two, 
owner misuse may be to blame for the increase of adverse events 
in smaller animals. In an attempt to save money, owners might 
purchase a dose meant for large dogs and then divide that dose up 
among multiple small dogs, resulting in a dose that is still too high. 
In the case of cats, the EPA found a high number of adverse events 
associated with owners using pyrethrin/pyrethroid-containing 
products meant for dogs only, despite warnings on the product 
labels that the treatment was not to be used on cats. Three, small 
dogs might be more naturally susceptible to the use of spot-on 
treatments because of biological characteristics specific to the 
individual animal, even when the correct dose is used. Therefore, 
it is important for the veterinarian–client–patient relationship to 
be maintained, as the EPA has suggested that pet owners who 
purchase spot-on treatments from their veterinarians receive 
more guidance for their correct usage.
Veterinarians may also be able to aid in choosing an ectopara-
siticide that is in fact effective. Some insects are becoming resist-
ant to certain insecticides. This characteristic is referred to as 
knockdown resistance (kdr) and seems to be prevalent in the case 
of pyrethroids (13). Some species of lice and ticks have already 
shown to be resistant to pyrethroids, and research suggests that 
mutations in the genes that form the voltage-gated Na+ ion 
channels are responsible for kdr. However, owners might believe 
that resistance exists when in fact a spot-on treatment does 
work, especially in the case of fipronil. According to Michael W. 
Dryden, “It can take time for a flea infestation to be gone, and that 
has nothing to do with resistance” (14), when speaking of owners 
claiming that their spot-on treatments that contain fipronil were 
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no longer working. Currently, the practice of using a product hav-
ing multiple insecticides is common because they provide broad 
spectrum activity. Ectoparasiticides, such as Parastar® Plus, need 
to be used as directed by the manufacturer and veterinarians and 
reapplied at the correct (as indicated earlier) and consistent times 
(once a month) to obtain the highest efficacy and safety.
Although findings of the current study have shown that the use 
of Parastar® Plus is safe for both dogs and humans, further inves-
tigation is warranted on a larger sample size, dogs of different 
weight categories, and long-term exposure to Parastar® Plus to 
observe for any adverse effects. Long-term exposure to Parastar® 
Plus may result in detectable residue of fipronil and cyphenothrin 
in dog blood and adverse effects in dogs and greater amounts 
of residues transferred from dogs to humans. This may require 
detailed biological monitoring of fipronil and cyphenothrin in 
dogs as well as humans in our future studies.
Poisonings in dogs and cats due to fipronil or cyphenothrin 
commonly occur as a result of accidental or intentional ingestion. 
In humans, poisoning is mainly due to accident or suicide attempt 
(15–17). In this context, authors are compelled to provide a brief 
discussion of mechanism of action and toxicity of fipronil and 
cyphenothrin in this paper. Common clinical signs of fipronil 
toxicosis are of CNS hyper excitability, including tremors, 
convulsions, seizures, and death (5). Fipronil is a selective non-
competitive blocker of the γ-aminobutyric acid (GABA)-gated 
chloride channel, manifesting high target specificity between 
insects versus mammals (18, 19). GABA is an inhibitory neu-
rotransmitter in the insect and mammalian CNS. Following 
blockage of the GABA-gated chloride channels, hyperexcitation 
occurs due to abated GABA-induced inhibitory effect, leading to 
characteristic convulsions, followed by paralysis and death (5). 
Fipronil-induced clinical signs in humans may include headache, 
dizziness, fatigue, and itching and irritation of the skin and eyes. 
Interestingly, a most recent study suggests that a fipronil metabo-
lite fipronil sulfone is more toxic than fipronil itself (20).
Most type I and type II pyrethroids are classified based on the 
symptoms they produce, but cyphenothrin represents an inter-
mediate pyrethroid. While it is a type II pyrethroid, the symptoms 
it produces are a combination of whole body tremors (T) and 
choreoathetosis–salivation (CS) syndrome (21–23). This combi-
nation of clinical signs is referred to as TS syndrome. Pyrethroids 
target the voltage-sensitive sodium (Na+) ion channels, causing a 
depolarization-dependent blockage that holds the channel open 
for an extended period of time, thereby suppressing the action 
potential (24, 25). Prolonged opening of the Na+ ion channels in 
the presence of a type II pyrethroid causes type II syndrome or 
CS syndrome, characterized by burrowing and pawing behaviors, 
hypersalivation, and ataxia, that progresses to writhing spasms, 
tonic seizures, and death (22, 24, 26). Type I pyrethroids are rec-
ognized for causing a similar but still distinguishable condition 
referred to as type I or T syndrome. Symptoms of T syndrome are 
aggressive sparring, clonic seizures, rigor, and death (22).
While both fipronil and cyphenothrin exhibit high target 
specificity for insects as compared to mammals, due to differ-
ences in the CNS, body temperature, and body size (18, 19, 
27, 28), safety concerns dealing with accidental poisoning and 
exposure to humans exist, especially for people who have higher 
exposure rates to dogs treated with ectoparasiticides (veterinary 
professionals, dog trainers, military, and police professionals) 
compared to the general public. Fipronil is classified as a Group C: 
possible human carcinogen, which, according to the United States 
EPA (29), includes “agents with limited animal evidence and lit-
tle or no human data” upon which to establish carcinogenicity. 
Fipronil’s oral LD50 is 97 mg/kg, and its dermal LD50 is >2000 mg/
kg. Studies strongly suggest that fipronil is an endocrine disrup-
tor (30, 31). Cyphenothrin is grouped into Toxicity Class III: 
chemicals that represent low toxicity and are labeled with the 
EPA signal word CAUTION. According to the National Pesticide 
Information Center (32), chemicals designated under this class 
are “slightly toxic if eaten, absorbed through the skin, inhaled,” or 
they cause “moderate eye or skin irritation.” Cyphenothrin’s oral 
LD50 is 318 mg/kg, and its dermal LD50 is >5000 mg/kg. These low 
dermal LD50 data suggest that mammalian toxicity via skin contact 
with Parastar® Plus is of low risk in most animals and humans. 
Biomarkers that could aid in detecting various facets of toxicity of 
fipronil and pyrethrins/pyrethroids have been described recently 
by Gupta and Milatovic (33).
conclusion and Future Direction
Taken together, findings of this study suggests that if used in accord-
ance with manufacturer’s instructions and allowed 24  h to dry, 
Parastar® Plus is a safe topical ectoparasiticide and does not pose 
a threat to the health of dogs or the people who come into contact 
with them. Since veterinary personnel have direct physical contact 
with multiple dogs every day, they should observe the proper use 
of PPE in order to protect themselves against cumulative exposure 
to Parastar® Plus, as at this time, long-term studies of transferable 
residues from the combination of fipronil and cyphenothrin have 
not been completed. In the present investigation, we did not observe 
eye or skin irritation; in future studies, we will perform histopathol-
ogy of dermal biopsy at the site of Parastar® Plus application.
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